LLC J.H. Whitney Equity Partners Vii Sells Shares in Aveanna Healthcare

LLC J.H. Whitney Equity Partners Vii sold 919,389 shares of Aveanna Healthcare Holdings Inc. (NasdaqGS: AVAH) on June 24, 2026. The transaction was valued at approximately $7.36 million, with shares sold at an average price of $8.00 each.

What Changed in LLC J.H. Whitney Equity Partners Vii's Aveanna Healthcare Position

The sale of 919,389 shares by LLC J.H. Whitney Equity Partners Vii represents a significant divestment in Aveanna Healthcare Holdings. This transaction was not part of a pre-planned trading program.

Other Institutional Activity in Aveanna Healthcare

Institutional investors have shown varied interest in Aveanna Healthcare. Nut Tree Capital Management, LP increased its stake by 550,000 shares, bringing its total to 12,922,649 shares worth approximately $83.2 million, a 4.4% increase. Conversely, BlackRock, Inc. reduced its position by 656,532 shares, now holding 5,500,912 shares valued at about $35.4 million, marking a 10.7% decrease. Meanwhile, Summit Partners L P cut its stake by 2,100,000 shares, resulting in 5,451,422 shares worth close to $35.1 million, a 27.8% decrease. Vanguard Capital Management LLC opened a new position with 3,974,819 shares valued at approximately $25.6 million.

Aveanna Healthcare Holdings Inc. Stock Down 35.0%

Shares of Aveanna Healthcare traded near $8.48 on Saturday. The company has a market capitalization of around $1.89 billion and a P/E ratio of 7.16, with a forward P/E of 11.24. Aveanna's stock has a 52-week range between $3.73 and $10.32, and its 50-day and 200-day moving averages are $7.10 and $7.98, respectively. The company's beta is 1.93, indicating higher volatility compared to the market average.

Recent Earnings

Aveanna Healthcare reported revenue of approximately $2.52 billion, with a growth rate of 15.9%. The company achieved a net margin of 10.37% and a return on equity of 3.68%. Its earnings per share stood at $1.21. The next earnings release is anticipated on August 6, 2026.

Insider Buying and Selling at Aveanna Healthcare Holdings Inc.

On June 24, 2026, LLC J.H. Whitney Equity Partners VII sold 919,389 shares at $8.00 each. On the same day, Paul Vigano and Robert Williams Jr. each sold 1,000,000 shares at the same price. Earlier in the month, on June 3, 2026, Paul Vigano and Robert Williams Jr. also sold 7,000,000 shares each at $6.24, along with LLC J.H. Whitney Equity Partners VII, which sold 5,842,240 shares at the same price.

Analysts Set New Price Targets

On May 18, 2026, Barclays maintained its 'buy' rating for Aveanna Healthcare with a price target of $9.00. On May 15, 2026, Stephens & Co. upgraded the stock to a 'buy' with a target of $11.00. RBC Capital also maintained a 'hold' rating with a $10.00 target on the same date.

About Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc. is a healthcare company based in Atlanta, Georgia, specializing in pediatric and adult home care services. It operates through three main segments: Private Duty Services, Home Health & Hospice, and Medical Solutions. The company offers a range of services, including in-home skilled nursing, therapy services, and enteral nutrition supplies. Aveanna aims to provide patient-centered care that allows individuals to remain in their homes rather than in high-cost care settings.

Bottom Line

The recent insider sales at Aveanna Healthcare Holdings by LLC J.H. Whitney Equity Partners Vii and other insiders reflect a notable reduction in their holdings. Investors and analysts continue to keep a close watch on Aveanna's financial performance and market position, especially given the company's robust revenue growth and upcoming earnings report on August 6, 2026. As always, it's important to remember that insider transactions are reported after the fact and may not signal future stock performance.